Skip Navigation


Brain Advance Access originally published online on June 30, 2006
Brain 2006 129(9):2363-2374; doi:10.1093/brain/awl161
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/9/2363    most recent
awl161v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bosley, T. M.
Right arrow Articles by Engle, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosley, T. M.
Right arrow Articles by Engle, E. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Neurological features of congenital fibrosis of the extraocular muscles type 2 with mutations in PHOX2A

Thomas M. Bosley1,{dagger}, Darren T. Oystreck2, Richard L. Robertson4, Abdulaziz al Awad2, Khaled Abu-Amero3 and Elizabeth C. Engle5,6,7

1 Neuro-ophthalmology Division, King Khaled Eye Specialist Hospital (KKESH) Riyadh, Saudi Arabia 2 Pediatric Ophthalmology Division, King Khaled Eye Specialist Hospital (KKESH) Riyadh, Saudi Arabia 3 Department of Genetics, King Faisal Specialist Hospital and Research Centre Riyadh, Saudi Arabia 4 Department of Radiology, Children's Hospital Boston Boston, MA, USA 5 Program in Genomics, Children's Hospital Boston Boston, MA, USA 6 Department of Neurology, Children's Hospital Boston Boston, MA, USA 7 Program in Neuroscience, Division of Medical Sciences, Harvard Medical School Boston, MA, USA

Correspondence to: Thomas M. Bosley, Division of Neurology, Suite 320, 3 Cooper Plaza, Cooper University Hospital, Camden, NJ, 08103, USA and Elizabeth C. Engle, Program in Genomics and Department of Neurology, Enders 560.2, Children's Hospital Boston, 300 Longwood Ave, Boston, MA 02115, USA E-mail: Thomas{at}CooperHealth.edu and elizabeth.engle{at}childrens.harvard.edu

Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a complex strabismus syndrome that results from mutations in the homeodomain transcription factor PHOX2A. To define the clinical and neuroimaging features of patients with this autosomal recessive syndrome, we studied 15 patients with genetically defined CFEOM2. All patients underwent full neurological, neuro-ophthalmological and orthoptic assessments. Twelve patients had pupillary pharmacological testing and nine had 3.0 tesla MRI of the brain, brainstem and orbits. Patients were born with severe bilateral ptosis and exotropia with almost complete bilateral absence of adduction, elevation, depression and intorsion. Variable abduction was present prior to strabismus surgery in 14 patients, and central ocular motility reflexes (smooth pursuit, saccades, vestibulo-ocular reflex and optokinetic reflex) were intact except for convergence. Pupillary light and near reflexes were not present, but irises were anatomically normal and responded to pupillary pharmacology. Neuroimaging of brain and brainstem was remarkable for the anatomical absence of cranial nerve (CN) 3 and probably CN 4 bilaterally. Therefore, the CFEOM2 phenotype and neuroimaging are both consistent with the congenital absence of CNs 3 and 4. Additional features included presence of most central ocular motility reflexes, a central lack of pupillary responsiveness of uncertain aetiology and modest phenotypic variability that does not correlate with specific PHOX2A mutations. Clinical presentation, neuroimaging and Phox2a–/– animal models all support the concept that CFEOM2 is a primary neurogenic abnormality with secondary myopathic changes.

Key Words: brain imaging; brain development; ocular motor nerve; congenital ophthalmoplegia

Abbreviations: CCDDs, congenital cranial dysinnervation disorders; CFEOM2, congenital fibrosis of the extraocular muscles type 2; CN, cranial nerve; EOM, extraocular muscle

.

Received March 17, 2006. Revised May 16, 2006. Accepted May 20, 2006.


{dagger}Dr Bosley is now in the Neurology Division, Cooper University Hospital, Camden, NJ, USA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
R. S. Antunes-Foschini, D. Miyashita, H. E. A. Bicas, and L. K. McLoon
Activated Satellite Cells in Medial Rectus Muscles of Patients with Strabismus
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 215 - 220.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
E. C. Engle
Genetic Basis of Congenital Strabismus
Arch Ophthalmol, February 1, 2007; 125(2): 189 - 195.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.